{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:57:37Z","timestamp":1790470657499,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Lassa hemorrhagic fever (LHF) is a rodent-borne viral disease that can be fatal for human beings. In this study, an attenuated Lassa vaccine candidate, ML29, was tested in SIV-infected rhesus macaques for its ability to elicit immune responses without instigating signs pathognomonic for arenavirus disease. ML29 is a reassortant between Lassa and Mopeia viruses that causes a transient infection in non-human primates and confers sterilizing protection from lethal Lassa viral challenge. However, since the LHF endemic area of West Africa also has high HIV seroprevalence, it is important to determine whether vaccination could be safe in the context of HIV infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>SIV-infected and uninfected rhesus macaques were vaccinated with the ML29 virus and monitored for specific humoral and cellular immune responses, as well as for classical and non-classical signs of arenavirus disease. Classical disease signs included viremia, rash, respiratory distress, malaise, high liver enzyme levels, and virus invasion of the central nervous system. Non-classical signs, derived from profiling the blood transcriptome of virulent and non-virulent arenavirus infections, included increased expression of interferon-stimulated genes (ISG) and decreased expression of COX2, IL-1\u03b2, coagulation intermediates and nuclear receptors needed for stress signaling. All vaccinated monkeys showed ML29-specific antibody responses and ML29-specific cell-mediated immunity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>SIV-infected and uninfected rhesus macaques responded similarly to ML29 vaccination, and none developed chronic arenavirus infection. Importantly, none of the macaques developed signs, classical or non-classical, of arenavirus disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-422x-10-52","type":"journal-article","created":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T11:15:48Z","timestamp":1360667748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity"],"prefix":"10.1186","volume":"10","author":[{"given":"Juan C","family":"Zapata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhawna","family":"Poonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Ateh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanea","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oswald","family":"Crasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Slezak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Jaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C David","family":"Pauza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Goicochea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Moshkoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor S","family":"Lukashevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S","family":"Salvato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,12]]},"reference":[{"key":"2064_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-3-642-71726-0_10","volume":"134","author":"SP Fisher-Hoch","year":"1987","unstructured":"Fisher-Hoch SP, McCormick JB: Pathophysiology and treatment of Lassa fever. Curr Top Microbiol Immunol 1987, 134: 231-239. 10.1007\/978-3-642-71726-0_10","journal-title":"Curr Top Microbiol Immunol"},{"key":"2064_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","volume":"311","author":"SP Fisher-Hoch","year":"1995","unstructured":"Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagner L, McCormick JB: Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 1995, 311: 857-859. 10.1136\/bmj.311.7009.857","journal-title":"BMJ"},{"key":"2064_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/infdis\/155.3.456","volume":"155","author":"KM Johnson","year":"1987","unstructured":"Johnson KM, McCormick JB, Webb PA, Smith ES, Elliott LH, King IJ: Clinical virology of Lassa fever in hospitalized patients. J Infect Dis 1987, 155: 456-464. 10.1093\/infdis\/155.3.456","journal-title":"J Infect Dis"},{"key":"2064_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/7422","volume":"5","author":"S Baize","year":"1999","unstructured":"Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debre P, Fisher-Hoch SP, McCormick JB, Georges AJ: Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999, 5: 423-426. 10.1038\/7422","journal-title":"Nat Med"},{"key":"2064_CR5","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.1128\/JVI.01948-08","volume":"83","author":"S Baize","year":"2009","unstructured":"Baize S, Marianneau P, Loth P, Reynard S, Journeaux A, Chevallier M, Tordo N, Deubel V, Contamin H: Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. J Virol 2009, 83: 5890-5903. 10.1128\/JVI.01948-08","journal-title":"J Virol"},{"key":"2064_CR6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4269\/ajtmh.1986.35.401","volume":"35","author":"JB McCormick","year":"1986","unstructured":"McCormick JB, Walker DH, King IJ, Webb PA, Elliott LH, Whitfield SG, Johnson KM: Lassa virus hepatitis: a study of fatal Lassa fever in humans. Am J Trop Med Hyg 1986, 35: 401-407.","journal-title":"Am J Trop Med Hyg"},{"key":"2064_CR7","volume-title":"Vaccines against Lassa Fever","author":"MS Salvato","year":"2009","unstructured":"Salvato MS, Lukashevich IS: Vaccines against Lassa Fever. New York: Marcel Dekker, Inc; 2009."},{"key":"2064_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1073\/pnas.86.1.317","volume":"86","author":"SP Fisher-Hoch","year":"1989","unstructured":"Fisher-Hoch SP, McCormick JB, Auperin D, Brown BG, Castor M, Perez G, Ruo S, Conaty A, Brammer L, Bauer S: Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc Natl Acad Sci USA 1989, 86: 317-321. 10.1073\/pnas.86.1.317","journal-title":"Proc Natl Acad Sci USA"},{"key":"2064_CR9","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","volume":"2","author":"TW Geisbert","year":"2005","unstructured":"Geisbert TW, Jones S, Fritz EA, Shurtleff AC, Geisbert JB, Liebscher R, Grolla A, Stroher U, Fernando L, Daddario KM: Development of a new vaccine for the prevention of Lassa fever. PLoS Med 2005, 2: e183. 10.1371\/journal.pmed.0020183","journal-title":"PLoS Med"},{"key":"2064_CR10","doi-asserted-by":"publisher","first-page":"13934","DOI":"10.1128\/JVI.79.22.13934-13942.2005","volume":"79","author":"IS Lukashevich","year":"2005","unstructured":"Lukashevich IS, Patterson J, Carrion R, Moshkoff D, Ticer A, Zapata J, Brasky K, Geiger R, Hubbard GB, Bryant J, Salvato MS: A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses. J Virol 2005, 79: 13934-13942. 10.1128\/JVI.79.22.13934-13942.2005","journal-title":"J Virol"},{"key":"2064_CR11","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1016\/j.vaccine.2008.07.057","volume":"26","author":"IS Lukashevich","year":"2008","unstructured":"Lukashevich IS, Carrion R Jr, Salvato MS, Mansfield K, Brasky K, Zapata J, Cairo C, Goicochea M, Hoosien GE, Ticer A: Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates. Vaccine 2008, 26: 5246-5254. 10.1016\/j.vaccine.2008.07.057","journal-title":"Vaccine"},{"key":"2064_CR12","doi-asserted-by":"publisher","first-page":"6482","DOI":"10.1128\/JVI.02876-06","volume":"81","author":"R Carrion Jr","year":"2007","unstructured":"Carrion R Jr, Brasky K, Mansfield K, Johnson C, Gonzales M, Ticer A, Lukashevich I, Tardif S, Patterson J: Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues. J Virol 2007, 81: 6482-6490. 10.1128\/JVI.02876-06","journal-title":"J Virol"},{"key":"2064_CR13","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.3390\/v4112514","volume":"4","author":"IS Lukashevich","year":"2013","unstructured":"Lukashevich IS: Advanced Vaccine Candidates for Lassa Fever\". Viruses 2013, 4: 2514-2557.","journal-title":"Viruses"},{"key":"2064_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.virol.2005.12.001","volume":"345","author":"PJ Bredenbeek","year":"2006","unstructured":"Bredenbeek PJ, Molenkamp R, Spaan WJ, Deubel V, Marianneau P, Salvato MS, Moshkoff D, Zapata J, Tikhonov I, Patterson J: A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. Virology 2006, 345: 299-304. 10.1016\/j.virol.2005.12.001","journal-title":"Virology"},{"key":"2064_CR15","first-page":"525","volume":"12","author":"O Aina","year":"2005","unstructured":"Aina O, Dadik J, Charurat M, Amangaman P, Gurumdi S, Mang E, Guyit R, Lar N, Datong P, Daniyam C: Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult Nigerians. Clin Diagn Lab Immunol 2005, 12: 525-530.","journal-title":"Clin Diagn Lab Immunol"},{"key":"2064_CR16","doi-asserted-by":"publisher","first-page":"14926","DOI":"10.1073\/pnas.1112149108","volume":"108","author":"JF Papin","year":"2011","unstructured":"Papin JF, Verardi PH, Jones LA, Monge-Navarro F, Brault AC, Holbrook MR, Worthy MN, Freiberg AN, Yilma TD: Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice. Proc Natl Acad Sci USA 2011, 108: 14926-14931. 10.1073\/pnas.1112149108","journal-title":"Proc Natl Acad Sci USA"},{"key":"2064_CR17","doi-asserted-by":"publisher","first-page":"e1000225","DOI":"10.1371\/journal.ppat.1000225","volume":"4","author":"TW Geisbert","year":"2008","unstructured":"Geisbert TW, Daddario-Dicaprio KM, Lewis MG, Geisbert JB, Grolla A, Leung A, Paragas J, Matthias L, Smith MA, Jones SM: Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates. PLoS Pathog 2008, 4: e1000225. 10.1371\/journal.ppat.1000225","journal-title":"PLoS Pathog"},{"key":"2064_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1086\/427265","volume":"191","author":"Y Edghill-Smith","year":"2005","unstructured":"Edghill-Smith Y, Bray M, Whitehouse CA, Miller D, Mucker E, Manischewitz J, King LR, Robert-Guroff M, Hryniewicz A, Venzon D: Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge. J Infect Dis 2005, 191: 372-381. 10.1086\/427265","journal-title":"J Infect Dis"},{"key":"2064_CR19","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1182\/blood-2009-02-202655","volume":"114","author":"B Poonia","year":"2009","unstructured":"Poonia B, Salvato MS, Yagita H, Maeda T, Okumura K, Pauza CD: Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus. Blood 2009, 114: 1196-1204. 10.1182\/blood-2009-02-202655","journal-title":"Blood"},{"key":"2064_CR20","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1016\/j.vaccine.2007.02.038","volume":"25","author":"R Carrion Jr","year":"2007","unstructured":"Carrion R Jr, Patterson JL, Johnson C, Gonzales M, Moreira CR, Ticer A, Brasky K, Hubbard GB, Moshkoff D, Zapata J: A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Vaccine 2007, 25: 4093-4102. 10.1016\/j.vaccine.2007.02.038","journal-title":"Vaccine"},{"key":"2064_CR21","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.vaccine.2011.12.134","volume":"30","author":"MA Goicochea","year":"2012","unstructured":"Goicochea MA, Zapata JC, Bryant J, Davis H, Salvato MS, Lukashevich IS: Evaluation of Lassa virus vaccine immunogenicity in a CBA\/J-ML29 mouse model. Vaccine 2012, 30: 1445-1452. 10.1016\/j.vaccine.2011.12.134","journal-title":"Vaccine"},{"key":"2064_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S0140-6736(79)90659-7","volume":"2","author":"MP Kiley","year":"1979","unstructured":"Kiley MP, Lange JV, Johnson KM: Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus. Lancet 1979, 2: 738.","journal-title":"Lancet"},{"key":"2064_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/978-3-642-71726-0_2","volume":"134","author":"CJ Peters","year":"1987","unstructured":"Peters CJ, Jahrling PB, Liu CT, Kenyon RH, McKee KT Jr, Barrera Oro JG: Experimental studies of arenaviral hemorrhagic fevers. Curr Top Microbiol Immunol 1987, 134: 5-68. 10.1007\/978-3-642-71726-0_2","journal-title":"Curr Top Microbiol Immunol"},{"key":"2064_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-3-642-71726-0_3","volume":"134","author":"JB McCormick","year":"1987","unstructured":"McCormick JB: Epidemiology and control of Lassa fever. Curr Top Microbiol Immunol 1987, 134: 69-78. 10.1007\/978-3-642-71726-0_3","journal-title":"Curr Top Microbiol Immunol"},{"key":"2064_CR25","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1089\/vbz.2010.0010","volume":"11","author":"B Borremans","year":"2011","unstructured":"Borremans B, Leirs H, Gryseels S, Gunther S, Makundi R, de Bellocq JG: Presence of Mopeia virus, an African arenavirus, related to biotope and individual rodent host characteristics: implications for virus transmission. Vector Borne Zoonotic Dis 2011, 11: 1125-1131. 10.1089\/vbz.2010.0010","journal-title":"Vector Borne Zoonotic Dis"},{"key":"2064_CR26","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/0042-6822(92)90514-P","volume":"188","author":"IS Lukashevich","year":"1992","unstructured":"Lukashevich IS: Generation of reassortants between African arenaviruses. Virology 1992, 188: 600-605. 10.1016\/0042-6822(92)90514-P","journal-title":"Virology"},{"key":"2064_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11262-006-0050-3","volume":"34","author":"DA Moshkoff","year":"2007","unstructured":"Moshkoff DA, Salvato MS, Lukashevich IS: Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses. Virus Genes 2007, 34: 169-176. 10.1007\/s11262-006-0050-3","journal-title":"Virus Genes"},{"key":"2064_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jmv.20000","volume":"72","author":"JD Rodas","year":"2004","unstructured":"Rodas JD, Lukashevich IS, Zapata JC, Cairo C, Tikhonov I, Djavani M, Pauza CD, Salvato MS: Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever. J Med Virol 2004, 72: 424-435. 10.1002\/jmv.20000","journal-title":"J Med Virol"},{"key":"2064_CR29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/1471-2164-11-668","volume":"11","author":"SN Gardner","year":"2010","unstructured":"Gardner SN, Jaing CJ, McLoughlin KS, Slezak TR: A microbial detection array (MDA) for viral and bacterial detection. BMC Genomics 2010, 11: 668. 10.1186\/1471-2164-11-668","journal-title":"BMC Genomics"},{"key":"2064_CR30","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1128\/JVI.02650-06","volume":"81","author":"MS Jones","year":"81","unstructured":"Jones MS, Harrach B, Ganac RD, Gozum MM, Dela Cruz WP, Riedel B, Pan C, Delwart EL, Schnurr DP: New adenovirus species found in a patient presenting with gastroenteritis. J Virol 81, 81: 5978-5984.","journal-title":"J Virol"},{"key":"2064_CR31","first-page":"185","volume":"32","author":"K Banyai","year":"2009","unstructured":"Banyai K, Martella V, Meleg E, Kisfali P, Peterfi Z, Benko M, Melegh B, Szucs G: Searching for HAdV-52, the putative gastroenteritis-associated human adenovirus serotype in Southern Hungary. New Microbiol 2009, 32: 185-188.","journal-title":"New Microbiol"},{"key":"2064_CR32","doi-asserted-by":"publisher","first-page":"e1000503","DOI":"10.1371\/journal.ppat.1000503","volume":"5","author":"S Roy","year":"2009","unstructured":"Roy S, Vandenberghe LH, Kryazhimskiy S, Grant R, Calcedo R, Yuan X, Keough M, Sandhu A, Wang Q, Medina-Jaszek CA: Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates. PLoS Pathog 2009, 5: e1000503. 10.1371\/journal.ppat.1000503","journal-title":"PLoS Pathog"},{"key":"2064_CR33","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1073\/pnas.93.13.6425","volume":"93","author":"AM Scharko","year":"1996","unstructured":"Scharko AM, Perlman SB, Hinds PW, Hanson JM, Uno H, Pauza CD: Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. Proc Natl Acad Sci USA 1996, 93: 6425-6430. 10.1073\/pnas.93.13.6425","journal-title":"Proc Natl Acad Sci USA"},{"key":"2064_CR34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1590\/S0074-02762009000400009","volume":"104","author":"JD Rodas","year":"2009","unstructured":"Rodas JD, Cairo C, Djavani M, Zapata JC, Ruckwardt T, Bryant J, Pauza CD, Lukashevich IS, Salvato MS: Circulating natural killer and gammadelta T cells decrease soon after infection of rhesus macaques with lymphocytic choriomeningitis virus. Mem Inst Oswaldo Cruz 2009, 104: 583-591. 10.1590\/S0074-02762009000400009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2064_CR35","doi-asserted-by":"publisher","first-page":"7960","DOI":"10.1128\/JVI.00536-07","volume":"81","author":"MM Djavani","year":"2007","unstructured":"Djavani MM, Crasta OR, Zapata JC, Fei Z, Folkerts O, Sobral B, Swindells M, Bryant J, Davis H, Pauza CD: Early blood profiles of virus infection in a monkey model for Lassa fever. J Virol 2007, 81: 7960-7973. 10.1128\/JVI.00536-07","journal-title":"J Virol"},{"key":"2064_CR36","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1128\/JVI.02199-06","volume":"81","author":"GC Bowick","year":"2007","unstructured":"Bowick GC, Fennewald SM, Scott EP, Zhang L, Elsom BL, Aronson JF, Spratt HM, Luxon BA, Gorenstein DG, Herzog NK: Identification of differentially activated cell-signaling networks associated with pichinde virus pathogenesis by using systems kinomics. J Virol 2007, 81: 1923-1933. 10.1128\/JVI.02199-06","journal-title":"J Virol"},{"key":"2064_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1089\/vim.2009.0034","volume":"22","author":"GC Bowick","year":"2009","unstructured":"Bowick GC, Fennewald SM, Zhang L, Yang X, Aronson JF, Shope RE, Luxon BA, Gorenstein DG, Herzog NK: Attenuated and lethal variants of Pichinde virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics. Viral Immunol 2009, 22: 457-462. 10.1089\/vim.2009.0034","journal-title":"Viral Immunol"},{"key":"2064_CR38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1099\/vir.0.82499-0","volume":"88","author":"SM Fennewald","year":"2007","unstructured":"Fennewald SM, Scott EP, Zhang L, Yang X, Aronson JF, Gorenstein DG, Luxon BA, Shope RE, Beasley DW, Barrett AD, Herzog NK: Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections. J Gen Virol 2007, 88: 981-990. 10.1099\/vir.0.82499-0","journal-title":"J Gen Virol"},{"key":"2064_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-3-642-56029-3_4","volume":"262","author":"JB McCormick","year":"2002","unstructured":"McCormick JB, Fisher-Hoch SP: Lassa fever. Curr Top Microbiol Immunol 2002, 262: 75-109. 10.1007\/978-3-642-56029-3_4","journal-title":"Curr Top Microbiol Immunol"},{"key":"2064_CR40","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1128\/JVI.77.3.1727-1737.2003","volume":"77","author":"IS Lukashevich","year":"2003","unstructured":"Lukashevich IS, Tikhonov I, Rodas JD, Zapata JC, Yang Y, Djavani M, Salvato MS: Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. J Virol 2003, 77: 1727-1737. 10.1128\/JVI.77.3.1727-1737.2003","journal-title":"J Virol"},{"key":"2064_CR41","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1128\/jvi.68.12.8056-8063.1994","volume":"68","author":"M Matloubian","year":"1994","unstructured":"Matloubian M, Concepcion RJ, Ahmed R: CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 1994, 68: 8056-8063.","journal-title":"J Virol"},{"key":"2064_CR42","doi-asserted-by":"publisher","first-page":"e1000836","DOI":"10.1371\/journal.ppat.1000836","volume":"6","author":"L Flatz","year":"2010","unstructured":"Flatz L, Rieger T, Merkler D, Bergthaler A, Regen T, Schedensack M, Bestmann L, Verschoor A, Kreutzfeldt M, Bruck W: T cell-dependence of Lassa fever pathogenesis. PLoS Pathog 2010, 6: e1000836. 10.1371\/journal.ppat.1000836","journal-title":"PLoS Pathog"},{"key":"2064_CR43","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/1743-422X-8-314","volume":"8","author":"JN Grove","year":"2011","unstructured":"Grove JN, Branco LM, Boisen ML, Muncy IJ, Henderson LA, Schieffellin JS, Robinson JE, Bangura JJ, Fonnie M, Schoepp RJ: Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Virol J 2011, 8: 314. 10.1186\/1743-422X-8-314","journal-title":"Virol J"},{"key":"2064_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jmv.2206","volume":"67","author":"IS Lukashevich","year":"2002","unstructured":"Lukashevich IS, Djavani M, Rodas JD, Zapata JC, Usborne A, Emerson C, Mitchen J, Jahrling PB, Salvato MS: Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus. J Med Virol 2002, 67: 171-186. 10.1002\/jmv.2206","journal-title":"J Med Virol"},{"key":"2064_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1743-422X-6-20","volume":"6","author":"M Djavani","year":"2009","unstructured":"Djavani M, Crasta OR, Zhang Y, Zapata JC, Sobral B, Lechner MG, Bryant J, Davis H, Salvato MS: Gene expression in primate liver during viral hemorrhagic fever. Virol J 2009, 6: 20. 10.1186\/1743-422X-6-20","journal-title":"Virol J"},{"key":"2064_CR46","doi-asserted-by":"crossref","first-page":"7649","DOI":"10.1128\/jvi.68.11.7649-7653.1994","volume":"68","author":"P Trivedi","year":"1994","unstructured":"Trivedi P, Meyer KK, Streblow DN, Preuninger BL, Schultz KT, Pauza CD: Selective amplification of simian immunodeficiency virus genotypes after intrarectal inoculation of rhesus monkeys. J Virol 1994, 68: 7649-7653.","journal-title":"J Virol"},{"key":"2064_CR47","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/00007890-197105000-00010","volume":"11","author":"D Tripodi","year":"1971","unstructured":"Tripodi D, Lyons S, Davies D: Separation of peripheral leukocytes by Ficoll density gradient centrifugation. Transplantation 1971, 11: 487-488. 10.1097\/00007890-197105000-00010","journal-title":"Transplantation"},{"issue":"Pt 10","key":"2064_CR48","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1099\/0022-1317-79-10-2461","volume":"79","author":"M Dykhuizen","year":"1998","unstructured":"Dykhuizen M, Mitchen JL, Montefiori DC, Thomson J, Acker L, Lardy H, Pauza CD: Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression. J Gen Virol 1998,79(Pt 10):2461-2467.","journal-title":"J Gen Virol"},{"key":"2064_CR49","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1126\/science.272.5265.1167","volume":"272","author":"JW Mellors","year":"1996","unstructured":"Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272: 1167-1170. 10.1126\/science.272.5265.1167","journal-title":"Science"},{"key":"2064_CR50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7827-2-54","volume":"2","author":"CI Ace","year":"2004","unstructured":"Ace CI, Okulicz WC: Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase. Reprod Biol Endocrinol 2004, 2: 54. 10.1186\/1477-7827-2-54","journal-title":"Reprod Biol Endocrinol"},{"key":"2064_CR51","doi-asserted-by":"publisher","first-page":"15190","DOI":"10.1073\/pnas.0405759101","volume":"101","author":"KH Rubins","year":"2004","unstructured":"Rubins KH, Hensley LE, Jahrling PB, Whitney AR, Geisbert TW, Huggins JW, Owen A, Leduc JW, Brown PO, Relman DA: The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci USA 2004, 101: 15190-15195. 10.1073\/pnas.0405759101","journal-title":"Proc Natl Acad Sci USA"},{"key":"2064_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1471-2105-5-165","volume":"5","author":"Z Wang","year":"2004","unstructured":"Wang Z, Lewis MG, Nau ME, Arnold A, Vahey MT: Identification and utilization of inter-species conserved (ISC) probesets on Affymetrix human GeneChip platforms for the optimization of the assessment of expression patterns in non human primate (NHP) samples. BMC Bioinformatics 2004, 5: 165. 10.1186\/1471-2105-5-165","journal-title":"BMC Bioinformatics"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-10-52.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:38:37Z","timestamp":1630535917000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-10-52"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,12]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2064"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-10-52","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,12]]},"assertion":[{"value":"9 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"52"}}